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ABSTRACT 
 
Sasha Jane Betz: Evaluating histologic grading systems and the expression of human 
cytomegalovirus in salivary gland mucoepidermoid carcinoma 
(Under the direction of Ricardo J. Padilla) 
Mucoepidermoid carcinoma (sMEC) is the most common salivary gland malignancy. 
Traditionally, these tumors are histologically graded using point-based systems. Accurate 
grading is needed to guide treatment; however, current systems are criticized as inconsistent and 
cumbersome. The finding of human cytomegalovirus (hCMV) as causative to the development 
of sMEC suggests viral activity may influence tumor grade. 
Twenty-three sMEC specimens were independently graded by two oral pathologists and 
one oral pathology resident using both the Armed Forces Institute of Pathology (AFIP) and 
Brandwein methods. Inter-observer agreement and predictive value to patient outcome were 
statistically analyzed. sMEC specimens were then immunohistochemically evaluated using 
antibodies to two different hCMV proteins. 
Higher inter-observer agreement was observed with the AFIP grading method. Statistical 
significance was not achieved to assess the predictive value of either grading system. Detection 
of hCMV was negative with one of the antibodies used, while the other was equivocal.
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INTRODUCTION 
 Mucoepidermoid carcinoma is the most common malignancy of salivary glands.1 It 
comprises 10% of all salivary gland tumors and 35% of salivary gland malignancies.5 Clinical 
outcomes range from no evidence of disease after surgical resection to distant metastasis and 
death.6 Several grading systems were developed in attempts to predict these outcomes based on 
histopathological features; however, no single system has been universally adopted. 
Tumor grade is based on the microscopic features of a neoplasm. A low-grade 
designation indicates well-differentiated neoplastic cells. This infers that the cellular features 
closely resemble those of the tissue of origin, and these neoplasms tend to have less aggressive 
behavior.7 Conversely, high-grade neoplasms demonstrate loss of features of a mature cell 
population and are associated with aggressive behavior.7 Tumor grading is coupled with staging, 
or the extent of disease, to assess prognosis and guide treatment decisions.7 
Traditional histologic features that determine tumor grade include mitotic rate, necrosis, 
invasion into nerves and vessels, cellular pleomorphism, and anaplasia.7,8 High mitotic rates 
indicate a rapidly dividing and expanding cell population.7 In some cases, this growth occurs so 
quickly that the vasculature cannot support the tumor. With inadequate delivery of nutrients and 
oxygen, some neoplastic cells die, resulting in the pools of necrosis identified histologically.7 
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Both perinerual invasion (PNI) and lymphovascular invasion (LVI) allow for tumor 
spread to distant sites and are associated with metastasis.7,8 Cellular pleomorphism refers to 
variability in cellular and nuclear size and shape, and anaplasia indicates loss of differentiation.7  
These features are present when the malignant cells no longer function to their specialized 
purpose. 
Using these histologic criteria, in addition to others specific to features of 
mucoepidermoid carcinoma, multiple scoring systems were developed in an attempt to predict 
the behavior of this malignancy.3, 4, 9 Due to the lack of a consensus grading system and 
subjectivity in some of their criteria, better methods of grading sMEC are needed. 
Recent studies suggest a causal relationship between human cytomegalovirus (hCMV, 
human herpesvirus-5, HHV-5) and sMEC.2 hCMV infection is endemic, with positivity shown in 
every population examined through seroepidemiologic surveys.10 Its tropism for salivary gland 
epithelium was identified as early as 1932, when hCMV nuclear inclusions were observed in 
salivary ductal epithelial cells.11 hCMV remains in the latent cycle in the majority of individuals 
infected, but reactivation is seen in immunocompromised patients.11 The molecular mechanisms 
of viral transition from latency to the lytic cycle are not fully established; however, viral gene 
products can be used to detect transcriptionally active hCMV.12 These include gene products 
IE1-72, proven to be important in viral replication, and pp65, a protein thought to play a role in 
immune subversion and incorporation of additional proteins into the virion.13, 14 
With hCMV as a proposed etiologic agent for sMEC, we hypothesized that viral 
expression could be measured and used as a prognostic indicator of tumor behavior. In this 
study, two board-certified oral and maxillofacial pathologists and one oral and maxillofacial 
pathology resident evaluated twenty three mucoepidermoid carcinoma specimens by the two 
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most widely-adopted grading methods; the AFIP and Brandwein systems. Inter-observer 
agreement was assessed as well as correlation between tumor grade and clinical outcome. 
Immunohistochemical techniques were used to stain tumor tissue with antibodies to hCMV 
protiens IE1-72 and pp65. Reactivity was assessed microscopically. 
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CHAPTER 1: GRADING OF SALIVARY GLAND  
MUCOEPIDERMOID CARCINOMA 
Introduction 
Mucoepidermoid “tumor” was first named and characterized by Stewart et al (1945). 
Their group evaluated approximately 700 salivary gland neoplasms and found 45 that contained 
mucous, intermediate, and epidermoid cells. These cases were separated into categories of 
“benign” and “malignant” by correlating histologic appearance to clinical outcome. Features 
associated with a favorable outcome were the presence of multiple of the aforementioned cell 
types in large quantities, delineated margins, cystic spaces with mucous pools, and sheets or 
“plugs” of squamous epithelial cells. Conversely, features associated with malignancy included a 
predominance of epidermoid cells, anaplastic cells, infiltrative margins, and lack of large cystic 
spaces with mucous pools. It is emphasized that mucous cells, as demonstrated by a positive 
mucicarimine histochemical stain, must be present to render a diagnosis of mucoepidermoid 
tumor.1 
Foote et al (1953) further detailed these neoplasms in a review of tumors of the major 
salivary glands. Due to observed metastases in cases designated as benign, the authors 
recommended a three-tiered grading system and a malignant classification of all tumors. They 
separated 59 tumors into low, medium, and high histological grades, and correlated these to 
mortality. The medium grade tumors were stated to demonstrate histological features of greater 
similarity to those of low grade tumors, but the precise differences between grades was left to the 
interpretation of the reader.2
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In 1970, Healey et. al studied 60 cases of sMEC to elaborate criteria for grading and 
surgical management. Like Foote, the authors adopted a three-tiered system. Grade I was 
described as well differentiated or low-grade, Grade II as moderately differentiated or medium-
grade, and Grade III as poorly differentiated, high-grade neoplasms. Grade I lesions were 
characterized by cystic spaces lined by mucous-producing cells and epidermoid cells, having a 
tumor front that infiltrated surrounding tissues with broad borders, and in which mitotic figures 
were rare. Grade II sMECs comprised solid nests of intermediate or epidermoid cells. Cystic 
spaces contained increased intraluminal proliferations of intermediate and epidermoid cells as 
compared to Grade I tumors. The tumor front was less distinct and occasional mitotic figures 
were present. Grade III was defined by greater proportions of solid nests and glandular 
structures, but less cystic space. Pleomorphism, prominent nucleoli, brisk mitotic activity, and 
aggressive infiltration into adjacent tissue were appreciable. Like Stewart’s publication, 
mucicarmine positivity was emphasized as critical to the diagnosis.3 Batsakis et al (1990) 
summarized and made minor modifications to Healey’s grading criteria of sMEC (Table 1).4 
Spiro et al (1978) studied 367 cases of sMEC from the major and minor salivary glands 
and also adopted a 3-tiered system. The histologic criteria used for grading overlapped Healey’s, 
but focused on the predominance of different cell types within each grade. The low-grade tumors 
contained well-developed cystic structures lined by mucous cells. Increased solid areas of 
epidermoid, squamous, or basaloid cells were observed in intermediate grade lesions; but cystic 
structures were also mentioned. The high-grade tumors had increased basaloid and epidermoid 
cells in solid nests or cords as well as prominent nucleoli and conspicuous mitoses. The 5-year 
DFS rate was 92%, 63%, and 27% for low, intermediate, and high grades, respectively. 
Submandibular gland tumors had a lower cure rate. This was theorized to be due to inadequate 
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initial surgery, which was usually simple excision rather than resection with wide margins, or a 
higher proportion of intermediate and high grade tumors. The authors concluded that the 
histologic grade correlated to the stage of the tumor, but due to instances of metastasis and 
tumor-related deaths in low grade lesions, all sMECs should be considered malignant.5 
Table 1: Grades of mucoepidermoid carcinomas and their histocytologic characteristics. 
Batsakis et al 1990. 
Grade 1 (Low) Grade 2 (Intermediate) Grade 3 (High) 
Macrocysts and microcysts: 
transitions with excretory ducts. 
No macrocysts; fewer microcysts; 
solid nests of cells. 
No macrocysts; preponderantly 
solid, but may be nearly all 
microcystic glandular. 
Differentiated mucin-producing 
cells and epidermoid cells, often in 
a 1:1 ratio; intermediate cell 
population minimal to moderate 
(focal). 
Intermediate cell preponderance with 
or without epidermoid 
differentiation: mucin-producing 
cells may be sparse. 
Dedifferentiated cells difficult to 
find, especially mucin-positive 
cells. 
Daughter cyst proliferation from 
larger cysts. 
Large duct population far less 
conspicuous. 
Cell constituents range from 
poorly differentiated to 
recognizable epidermoid and 
intermediate to ductal-type 
adenocarcinoma with epidermoid 
and intermediate cell participation. 
Minimal to absent pleomorphism; 
rare mitoses 
Slight to moderate pleomorphism; 
few mitoses; nuclei and nucleoli 
more prominent. 
Considerable pleomorphism; 
prominent nucleoli; easily found 
mitoses. 
Broad-front, often circumscribed 
invasion 
Invasive quality usually well-defined 
and uncircumscribed. 
Unquestioned invasion: soft tissue, 
perineural, and intravascular. 
Pools of extravasated mucin with 
stromal reaction (fibrosis, chronic 
inflammatory cells). 
Chronic inflammation at periphery; 
fibrosis separates nests of cells and 
groups of nests. 
Chronic inflammation less 
prominent; desmoplasia of stroma 
may outline invasive clusters. 
In 1991, Auclair et al evaluated 143 mucoepidermoid carcinomas from minor salivary 
glands. The cases were separated into four groups based on the disease course. Group 1 had no 
evidence of disease (NED) after initial treatment. Group 2 experienced recurrence after initial 
treatment but were free of disease at follow-up or death. Group 3 had lymph node metastasis 
with or without recurrence, but NED was present at follow-up or death. Group 4 comprised 
patients who died of disease (DOD). Twelve histological features were evaluated and correlated 
to clinical outcome by stepwise logistic regression. Anaplasia, mitotic rate, presence of neural 
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invasion, and proportion of cystic spaces showed statistically significant association to outcome. 
Too few tumors showed necrosis to achieve statistical power; however, the authors found this 
feature to be an important indicator when present. These five histologic criteria were weighted 
and incorporated into a proposed grading system (Table 2). The points for each group were 
compared with patient outcomes to define high, intermediate, and low tumor grades. This 
method became known as the Armed Forces Institute of Pathology (AFIP) grading system of 
mucoepidermoid carcinoma.6 
Table 2: Parameters used for grading intraoral mucoepidermoid carcinoma. Auclair et al 
1991. 
Parameter Point value 
Intracystic component <20% +2 
Neural invasion present +2 
Necrosis present +3 
Mitoses (4+ per 10 HPF) +3 
Anaplasia +4 
Low-grade: 0-4, Intermediate-grade: 5-6, High-grade: 7+ *HPF = high powered field 
 In a 1998 publication, Goode, Auclair, and Ellis applied the AFIP grading system to 
mucoepidermoid carcinoma of the major salivary glands. Two hundred thirty four cases were 
divided into four groups according to clinical outcome as elaborated previously. The tumors 
were then scored with the grading criteria outlined in Table 2.7 
When comparing Group 1 and Group 4 patients, independent statistical significance of 
each grading criteria was confirmed. Groups 1 and 2 had mean scores of 2.0 and 2.3, 
respectively, corroborating a favorable outcome to the assigned low-grade. Group 3 had a mean 
score of 3.75, with the majority of tumors exhibiting low-grade histologic features. The authors 
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explain that clinical factors such as large tumor size or conservative treatment may incite 
metastasis in this group of low-grade appearing neoplasms.7 
The average score of Group 4 tumors was 7.56. This score correlated a high-grade to 
poor prognosis; however, only 52% of these tumors were assigned high grades. Forty percent 
received a low-grade score. The tumor site accounted for some of this discrepancy, with 75% of 
Groups 3 and 4 tumors of the submandibular gland given a low histological grade. Conversely, 
33% of Group 4 parotid gland tumors were given low grades. The authors concluded that their 
grading system is useful for parotid tumors, but sMECs of the submandibular gland require 
aggressive treatment regardless of histological tumor grade.7 
 Brandwein et al evaluated the AFIP grading system on reproducibility and prediction of 
outcome in a 2001 publication. Five pathologists independently graded 20 hematoxylin and eosin 
(H&E) slides of different sMECs using their personal grading method as well as the AFIP 
grading system. Out of 100 pairs of results, there were 46 disagreements between the 
pathologist’s own grade and the AFIP grade. Forty five of these were “downgrades,” where a 
pathologist graded a tumor higher using their own criteria than the AFIP grade. In 8 of the 45, 
the AFIP grading system downgraded the tumor by 2 grades. In one case, the AFIP grade was 
higher than the pathologist’s.  Weighted kappa values were then averaged across observers to 
determine inter-observer agreement. The agreement between pairs of observers using their own 
grading criteria was ranged from poor to good (κ = 0.27 – 0.79, average κ = 0.49). Better 
agreement was found when observers used the AFIP system (κ = 0.38 – 0.77, average κ = 0.61). 
Their group evaluated surgical margin status, positive lymph nodes, distant metastasis, and 
disease free survival (DFS). Of 48 patients with follow up data, 10 had local recurrences 
associated with both increased tumor grade (log rank = 0.009) and a surgical margin less than 
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3mm (p = 0.048). Positive lymph nodes were identified in 33% (14). This correlated to increased 
tumor grade (p < 0.001), with 85% (12/14) corresponding to grade 3 tumors and the remaining 
15% (2/14) corresponding to grade 2 tumors. Three patients developed distant metastases, all 
with grade 3 tumors. Ultimately, 0% (0/12) of grade 1, 5% (1/20) of grade 2 and 65% (10/16) of 
grade 3 patients in their study population died of disease. Taken together, increased tumor grade 
correlated to increased morbidity and mortality.8 
The Brandwein group asserted that, based on their findings, the AFIP method 
downgraded tumors and they proposed a new grading system (Table 3). They re-graded 31 
tumors using their method and compared the outcomes to those predicted by the AFIP system. 
Statistical significance was not achieved in correlating tumors grades to DFS using either 
grading method; however, the p value showed greater correlation to DFS with the proposed 
Brandwein grading than the AFIP (p = 0.099 vs 0.249).8 
 The authors concluded that a standardized grading system improves reproducibility 
between observers. In contrast to the findings of Goode et al, no decreased prognosis of tumors 
of the submandibular gland was identified.7, 8 The discrepancy on the behavior of submandibular 
tumors was theorized to be due to surgical failure to obtain adequate margins for risk of 
sacrificing the marginal mandibular nerve in the resection.8 
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Table 3: Proposed grading system for mucoepidermoid carcinoma.  Brandwein et al 2001. 
Feature Points 
Intracystic component <25% +2 
Tumor front invades in small nests and islands +2 
Pronounced nuclear atypia +2 
Lymphatic and/or vascular invasion +3 
Bony invasion +3 
> 4 mitoses per 10 HPF +3 
Perineural spread +3 
Necrosis +3 
Low-grade: 0, Intermediate-grade: 2-3, High-grade: 4+ *HPF = high powered field 
 Since the proposal of the three aforementioned grading systems, numerous publications 
debated their prognostic value and reproducibility. In 2006, Luna et al graded 43 sMECs of the 
parotid with the modified Healey, AFIP, and Brandwein system. The modified Healey and 
Brandwein graded similarly, with only one instance of disagreement between the two systems. 
Their study echoed the tendency of the AFIP system to downgrade tumors. The authors stated 
that the point-based AFIP and Brandwein systems were easier to reproduce than the modified 
Healey system; however, this finding was not statistically quantified.9 
 Aro et al (2008) evaluated 52 cases of sMEC of the major glands by the AFIP criteria as 
well as cell proliferation rates, and correlated the grade to clinical outcome. Their sample size 
was small with 20 high-grade tumors, 7 intermediate-grade, 23 low-grade, and 2 of indeterminate 
grade. In agreement with the findings of Brandwein and Luna, their group found aggressive 
behavior in intermediate-grade tumors with a high incidence of lymph node metastasis and 
recurrence. The 3 year DFS was 100%, 33%, and 55% in low, intermediate, and high-grade 
tumors respectively. The authors conclude that in their experience, intermediate-grade tumors 
behave similarly to high-grade tumors, and necessitate aggressive treatment.10 
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 Later that year, a publication by Nance et al assessed 50 additional cases of sMEC from 
all sites in the head and neck, including larynx, trachea, and nasal cavity using the Brandwein 
grading method. No statistically significant differences were observed between low and 
intermediate-grades in either overall survival or DFS, and no patients in these groups DOD. 
There was statistical difference between high and low-grades and high and intermediate-grades 
by both measures (p<.001), and 52% of patients with high-grade tumors DOD. Loco-regional 
recurrence occurred in 30% (7/23) of high, 23% (3/13) intermediate, and 0% (0/14) low-grade 
cases. Based on a multivariate analysis, histologic grade was the only factor studied that affected 
both overall survival and DFS. The authors concluded that their study supports the predictive 
utility of the Brandwein method.11 
In a 2009 review, Seethala criticized the modified Healey, AFIP, and Brandwein grading 
systems as cumbersome with ill-defined criteria. He restated the concern of the AFIP system to 
downgrade tumors, but also the tendency of the Brandwein system to upgrade. It was 
emphasized that the results of these inaccuracies place patients at risk for under or over 
treatment, both of which can be associated with increased morbidity and/or mortality. The 
tumors of intermediate-grade were discussed as particularly concerning, with some studies 
clustering this group with low-grade behavior and others clustering them with high-grade. With 
the insipid nature of this category, the proper management of intermediate-grade tumors is 
unclear. However imperfect, Seethala advocated using a grading system for increased 
reproducibility. He recommended the Brandwein or Healey system as it is more acceptable for a 
high-grade tumor to run an indolent course than for a low-grade neoplasm to behave 
aggressively.12 
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Brandwein re-analyzed her grading system as compared to that of the AFIP in a 2013 
multi-institutional review of 76 patients. Forty one percent (31/76) of tumors were upgraded with 
the Brandwein method as compared to the AFIP. Most of the upgrades increased an AFIP Grade 
1 tumor to Brandwein Grade 2 (20/25), but a significant number increased to Brandwein Grade 3 
(5/25). Half of AFIP Grade 2 tumors were reclassified as Brandwein Grade 3 (5/10). It was noted 
that 6 patients with AFIP Grade 1 tumors experienced advanced disease beyond expected for a 
low grade. Three had positive cervical lymph node metastases, 2 experienced local recurrence, 
and 1 developed distant metastasis. Statistical power to determine predictive performance of 
each grading method was not achieved, however; and reliability between observers was not 
assessed.13 
With the prevalent issue of limited sample sizes in previous studies, Chen et al (2014) 
analyzed Surveillance, Epidemiology, End Result (SEER) data on sMEC of the parotid gland. 
Patient demographics, tumor characteristics, and survival were correlated to the tumor grade, but 
the method of grading was unknown. A total of 2,400 adult patients were identified between the 
years 1988 and 2009. Low-grade sMEC comprised 21.8%, intermediate-grade 47.4%, and high-
grade 30.9%. The demographic differences between low and intermediate-grades were not 
statistically significant. Both had increased prevalence in Caucasian females and mean ages of 
diagnosis of 52-52.8, respectively. In contrast, high-grade tumors were most common in 
Caucasian men and appeared at a later age (mean age of 66). No statistically significant 
difference was found between low and intermediate-grade tumors when comparing tumor size, 
with mean sizes of 2.0 cm and 2.1 cm, respectively (p = 0.56). Comparatively, the mean size of 
high-grade tumors was greater at 3.2 cm (p > 0.001). Intermediate and high-grade tumors were 
more likely to present with extraparenchymal extension than low-grade tumors (9.8% vs 18.7%, 
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p  < 0.001 and 51.7%, p < 0.001). The intermediate and high-grade tumors were also more likely 
to metastasize to regional lymph nodes (10.6% vs 15.9%, p = 0.03; and 56.8%, p < 0.001); 
however, only high-grade tumors were more likely to present with distant metastases (LG 0.2%, 
IG 0.3%, p > 0.99; HG 3.2%, p < 0.001).14 
 When evaluating the 5-year disease-specific survival (DSS), there was no statistically 
significant difference between low and intermediate-grade tumors (98.8% vs 97.4%, p = 0.09). 
High-grade tumors were associated with decreased 5 year DSS when compared to the grouped 
low and intermediate-grades (67.0% vs 97.8%, p < 0.001). By Cox multivariate regression, 
statistically significant indicators of decreased prognosis included histologic high-grade, 
increasing age, increasing tumor size, extra-parenchymal extension, positive lymph nodes, and 
distant metastasis.14 
 The authors concluded that the intermediate and low-grade sMECs were similar in patient 
demographics and survival. In contrast, high-grade sMECs were associated with male gender, 
older age at diagnosis, and significantly reduced survival. They attributed the published 
disparities of intermediate-grade behavior to the use of different grading systems. Because of 
proven reproducibility and use in WHO classification of head and neck tumors, the authors 
recommended use of the AFIP grading system.14 
 Compared to the small sample sizes studied in some of the previous literature on the 
grading of mucoepidermoid carcinoma, as seen in publications by Brandwein, Luna, and Aro, 
the SEER analysis offered a comprehensive investigation of the true behavior exhibited by 
different grades of sMEC.8, 9,10,14 Statistically significant differences between the low and 
intermediate-grade tumors in terms of extraparenchymal extension and metastasis to regional 
nodes were identified (9.8% vs 18.7%, p < 0.001; 10.6% vs 15.9%; p < 0.03); however, there 
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was no statistical difference in DSS. Although the authors endorsed the AFIP grading system, the 
method used by pathologists to grade the tumors included in the study was unknown.14 While 
multiple publications advocate use of a grading system, the question as to which method is best 
remains unanswered.  
Materials and Methods 
 This project was reviewed and approved by the University of North Carolina Institutional 
Review Board (IRB 14-2941). Twenty eight formalin fixed and paraffin embedded (FFPE) tissue 
blocks and their corresponding H&E glass slides of mucoepidermoid carcinoma specimens were 
retrieved from UNC Hospitals Department of Pathology archives. The accession dates ranged 
from January 1, 2001 to December 31, 2016. The inclusion criterion was diagnosis of 
mucoepidermoid carcinoma of salivary gland origin. Exclusion criteria were insufficient tissue 
for further study, unreadable H&E slides, and patient age less than 18. From these criteria, 23 
cases were selected for study. 
 Observers were provided with tables of both the Brandwein and AFIP grading criteria. 
Instructions were given to document the points and grade of each case per grading method. The 
observers independently graded the same slide from each of the 23 cases. Consensus was 
achieved at a round table discussion at a multi-headed microscope for any disagreement in tumor 
grade. The data generated was collected and tabulated after independent grading and after 
consensus grading. 
 Statistical analysis was performed using R software. Inter-observer agreement was 
calculated between each pair of observers and Fleiss’ kappa was used to evaluate agreement 
across all observers. Percent agreement was calculated between the consensus grade and the 
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original grade given at diagnosis using each grading method. One case was graded at diagnosis 
as low by the AFIP method and high by Brandwein. This was excluded from the calculations. 
Patient outcomes were assessed from the date of diagnosis to end points of last date of 
follow up or date of death. End dates were determined through review of the medical chart or 
through the NC State Center for Health Statistics. Log rank tests were used to correlate patient 
demographics and tumor characteristics to outcome. The staging data was unknown for 3 
patients. One case was a recurrence with the initial date of diagnosis unknown. This was 
excluded from the outcomes assessment. Statistical significance was set at p < 0.05. 
Results 
Reliability analysis: 
 There was higher agreement on tumor grade between observers when using the AFIP 
grading system over Brandwein (73.9% vs 78.3%; κ = 0.650 vs κ = 0.743) (Figure 1, Table 5). 
Kappa values from both systems fell within the “substantial agreement” range of the Landis and 
Koch table of kappa interpretation (Table 4).15 There was also higher agreement between the 
grade given at diagnosis and the consensus AFIP grade than the consensus Brandwein grade 
(81.8% vs 50.0%). Bias toward higher grading was noted in Grader 2 with both grading systems 
(Figure 1). 
Table 4: Agreement measures for categorical data. Landis et al (1977). 
κ value Strength of Agreement 
< 0.00 Poor 
0.00 – 0.20 Slight 
0.21 – 0.40 Fair 
0.41 – 0.60 Moderate 
0.61 – 0.80 Substantial 
0.81 – 1.00 Almost Perfect 
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Figure 1: Point distribution between observers using the Brandwein (top row) vs AFIP 
(bottom row) grading method. 
 
 
  
1
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Table 5: Grading and inter-observer agreement per case. 
Study 
Number 
Grade & 
Method at 
Diagnosis 
Grader 1 Grader 2 Grader 3 Consensus Grade 
Brandwein AFIP Brandwein AFIP Brandwein AFIP Brandwein AFIP 
1 L, AFIP H L* H I H I H I 
2 H, NS H H H H H H H H 
3 L, NS H L H L H L H L 
4 H, NS H H H H H H H H 
5 L, NS I L I L I L I L 
6 H, NS H H H H H H H H 
7 L, NS L* L I L I L I L 
8 H, NS H H H H H H H H 
9 ** I L L* L I L I L 
10 I, AFIP H I* H H H H H H 
11 H, NS H H H H H I* H H 
12 L, NS H L H H*˚ H L H L 
13 L, NS H L H L I* L I L 
14 I, NS L L L L L L L L 
15 I, NS I L I L L* L L L 
16 H, NS H H H H H H H H 
17 H, NS H H H H H H H H 
18 H, NS H H H H H I* H H 
19 H, AFIP H H H H H H H H 
20 L, AFIP L L L L L L L L 
21 H, NS H H H H H H H H 
22 L, NS H* L I L I L I L 
23 L, AFIP H* L I L I L I L 
H = high grade, I = intermediate grade, L = low grade.  NS = not specified.  *Disagreement with other two observers.  
*˚Disagreement of greater than 1 grade.  **Original diagnosis of “Low by AFIP, high by Brandwein.” 
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Outcomes Assessment: 
 Follow up data ranged from 3 months to over ll years (median 1.82 years). With a limited 
sample size, statistical significance was not achieved for most characteristics evaluated. Lymph 
node status was an exception, with positive nodes being correlated to increased mortality (p = 
0.046). Although not statistically significant, a 60% (6/10) death rate was observed in the male 
group versus 25% (3/12) in the female group. Patient demographics and tumor characteristics are 
summarized in Table 5. 
Table 6:  Patient demographics and tumor characteristics. 
 n Death p value 
Sex   p = 0.583 
Male 10 6  
Female 12 3  
Race   p = 0.146 
African American 6 2  
Hispanic 1 0  
Caucasian 10 2  
Unknown 5 5  
Grade: Brandwein   p = 0.107 
Low 3 0  
Intermediate 6 1  
High 13 8  
Grade: AFIP   p = 0.088 
Low 11 2  
Intermediate 1 0  
High 10 7  
Grade: Original Pathologist   p = 0.152 
Low 9 1  
Intermediate 2 0  
High 10 7  
Reported Tumor Size   p = 0.084 
T1 6 0  
T2 4 1  
T3 3 1  
T4 6 4  
Node Status   p = 0.046 
No positive nodes 13 2  
Positive nodes 6 4  
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 Statistical significance was not achieved to determine the prognostic value of either 
grading system (Figure 2). Due to the similar behavior between the low and intermediate grade 
tumors, these groups were combined to dichotomize the data (Figure 3). Statistical significance 
of the prognostic value of “high grade” versus “not high grade” tumors was achieved for both 
Brandwein and AFIP grading systems (p = 0.034 and p = 0.028, respectively). 
Figure 2: Kaplan-Meier plots of overall survival stratified by prognostic variables. 
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Figure 3: Kaplan-Meier plots of overall survival stratified by dichotomized grading 
systems. 
 
Discussion 
Patient demographics: 
 Among our cases, there was a slightly higher proportion of female patients than males 
with a ratio of 1.2:1, which is similar to those reported in the literature.5, 6, 7,11,14 The mean female 
age at diagnosis was 43.7 whereas the mean male age at diagnosis was 85.5. Multiple studies 
stated an increased incidence of high-grade in males, but, similar to our findings, this has not 
been statistically significant when controlled for age in multivariate analysis.6,7, 11,14 
Tumor characteristics: 
 Although our sample size was small and statistical significance was not achieved, several 
studies show decreased prognosis with increased tumor size.7,14 In our data, positive lymph 
nodes were statistically associated with adverse outcome (Figure 2). 
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Grading systems: 
Seethala outlined the ideal requirements of a grading system as: 
 Accurately predicts outcome 
 Can be used to stratify patients into distinct management categories 
 Applicable to all sites where the tumor is seen 
 Simple criteria 
 Quick and time efficient 
 Reproducible with minimal inter- and intra-observer variability 
Taking these criteria point by point, both the AFIP and Brandwein grading systems have support 
for their ability to predict patient outcome of low and high-grade tumors. Although statistical 
power was not achieved, the AFIP grading system correlated slightly better with patient outcome 
than the Brandwein system in our study (Figure 2). Several publications failed to prove a 
statistically significant difference in survival between the low and intermediate grade 
classifications, which was also identified in our study.11,14 This corresponds to the next point, as 
the similarities in behavior but differences in grade confounds the management of these 
intermediate cases. 
 A lack of statistically significant differences in patient outcome between low and 
intermediate grades raises the question of whether the treatment of these two grades should differ 
or whether the two grades should be combined. While survival was not affected, several studies 
have shown slightly increased recurrence and regional lymph node metastases of intermediate-
grade over low-grade tumors.10,11,14 The accepted treatment of low-grade sMECs is local 
excision whereas high-grade sMECs receive wide excision, often with neck dissection and post-
operative radiation.11,16 Further elucidation of the true behavior of intermediate-grade tumors is 
necessary to determine best treatment of this grade. 
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 Whether either set of grading criteria can be applied to all sites of sMEC is also 
ambiguous. Spiro and Goode noted a site-specific tendency for local metastasis in sMECs of the 
submandibular gland, with Goode advocating for aggressive treatment of these malignancies 
regardless of histological stage.5,7  This tendency was not reported in subsequent studies, 
however. Brandwein et al (2001) specifically disputed the finding and offered inadequate 
surgical margins as an explanation of the discrepancy.8 The lack of consensus is likely due to 
limited cases of the submandibular site. 
 The simplicity and time efficiency of a task are subjective measures, but could certainly 
be aided by objective criteria. The criterion of anaplasia (AFIP) or “prominent nuclear atypia” 
(Brandwein) may be better stated as variation of nuclear sizes, hyperchromasia, or prominent 
nucleoli. 
 The reproducibility of the grading system is perhaps one of the most important criteria, so 
as to ensure these malignancies are studied and measured through the same calibration. By this 
measure, the AFIP grading method was superior to the Brandwein. This may be due to the 
reduced number of criteria enhancing the simplicity of the system. The AFIP grading method is 
recommended in the World Health Organization’s literature and thus is likely the most widely 
adopted.17 As the largest study in the literature demonstrates the pathology community’s 
proficiency of determining “high grade” vs “not high grade” tumors, as well as the low grade 
behavior of the intermediate category, it is of utmost importance that a standard is universally 
adopted so these tumors may be more adequately studied.14 
Conclusions 
The AFIP grading system showed better reproducibility than the Brandwein grading 
system. Based on these findings, we recommend universal adoption of the AFIP grading system. 
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Statistical significance was not achieved to determine superior prognostic value of either grading 
system; however, the similar behavior between the low and intermediate grade tumors both in 
our study and others supports combining these grades into one. Further research incorporating 
multi-institutional studies evaluating the two grading systems and behavior of intermediate grade 
tumors is necessary to elucidate the behavior of this tumor grade. 
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CHAPTER 2: HUMAN CYTOMEGALOVIRUS EXPRESSION 
IN SALIVARY GLAND MUCOEPIDERMOID CARICINOMA 
Introduction 
 Since Agostinos Bassi’s paradigm-shifting discoveries in the mid-1800’s, infectious 
microorganisms are proven to cause significant human morbidity and mortality.1 In the 1890’s, 
Robert Koch detailed postulates, or criteria, necessary to establish a causal relationship between 
an agent and a disease.2 While these postulates explained etiologies of infectious diseases such as 
tuberculosis and cholera, the impact of microorganisms on human health expanded to include 
oncogenesis with the discovery of Epstein-Barr virus (EBV, human herpesvirus-4, HHV-4) in 
Burkitt lymphomas in 1964.3 In 1996, Koch’s postulates were revisited and updated to account 
for advances made in molecular identification of diseases including viruses.2 Seven tumor-
associated viruses, or oncoviruses, are now appreciated to play causative roles in human 
cancers.4 Two of these, EBV and Kaposi’s sarcoma herpesvirus 8 (KSV, human herpesvirus-8, 
HHV-8), are members of the herpesviridae family of DNA viruses. 
 Melnick et al reported a causal relationship between a third herpesvirus, human 
cytomegalovirus (hCMV), and mucoepidermoid carcinoma of salivary glands (sMEC). Their 
group first infected murine explanted salivary glands with mouse cytomegalovirus (mCMV). 
They identified dysplasia and cellular pleomorphism within the ductal epithelium of the infected 
glands as compared to the controls. They also found upregulation of a molecular pathway, the 
COX/AREG/EGFR/ERK signaling pathway, associated with oncogenesis.5
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In a second study by their group, two board-certified oral and maxillofacial pathologists 
graded 39 human sMEC specimens by the modified Healey system. Immunohistochemistry 
techniques were used to evaluate the tumor tissue with antibodies to hCMV proteins IE1-72 and 
pp65. IE1-72 reactivity, identified within the nuclei and/or cytoplasm, was identified in 38/39 of 
their tumors. It was reported that increased IE1-72 reactivity was associated with increased 
tumor grade; however, this finding was not objectively quantified. Reactivity to pp65 was also 
seen in the cytoplasm and nucleus of tumor cells, as well as in inflammatory cells within the 
tumor stroma. No reactivity of either antibody was identified in adjacent, normal salivary gland 
tissueThe authors concluded that their findings satisfied the causal criteria for hCMV etiology of 
sMEC by establishing that hCMV is present in most cases of sMEC, only the neoplastic tissue 
harbors the infectious agent, hCMV-specific gene expression was demonstrated at the cellular 
level and was positively correlated with sMEC severity, infection was correlated with an 
upregulation of an oncogenic signaling pathway, and mCMV induced malignant transformation 
in an in vitro animal model.6 
Based on these findings, we hypothesized that a correlation between hCMV IE1-72 and 
pp65 expression could be quantified and used as an adjunctive prognostic indicator in the 
pathologic grading of sMEC. 
Materials and Methods 
 This project was reviewed and approved by the University of North Carolina Institutional 
Review Board (IRB 14-2941). Twenty eight formalin-fixed and paraffin-embedded (FFPE) 
tissue blocks and their corresponding H&E glass slides of sMEC specimens were retrieved from 
UNC Hospitals Department of Pathology archives. The accession dates ranged from January 1, 
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2001 to December 31, 2016. Inclusion/exclusion criteria and grading methods were previously 
described in Chapter 1. 
 All immunohistochemical analyses were performed on 4 µm thick sections at the 
Translational Pathology Laboratory at the University of North Carolina at Chapel Hill. 
Commercial antibodies to IE1-72 (MAB810, clone 8B1.2, Millipore, Temecula, CA) and pp65 
(Cytomegalovirus PP65 antibody, Biorbyt, San Francisco, CA) were used for hCMV 
identification. Immunohistochemistry (IHC) was performed in the Bond fully-automated slide 
staining system (Leica Biosystems Inc., Buffalo Grove, IL). Slides were deparaffinized in Bond 
dewax solution (AR9222) and Bond wash solution (AR9590). Antigen retrieval was performed 
at 100 C° in Bond-epitope retrieval solution 1, pH 6.0 (AR9961) for 20 minutes. After 
pretreatment, pp65 (1:50 dilution) and IE1-72 (1:200 dilution) antibodies were applied for one 
hour. Bond polymer refine detection system (DS9800), a polymeric horseradish peroxidase-
linker conjugate system, was used for antibody detection. Stained slides were dehydrated and 
cover-slipped. 
Positive controls of hCMV infected gastrointestinal tissue were used for each antibody. 
Two sets of negative controls were used for each antibody. One of these comprised hCMV 
infected gastrointestinal tissue with no antibody. The other was histologically normal salivary 
gland lobules included in biopsy specimens of mucoceles from 12 patients approximately age-
sex matched to the study population. Fourteen specimens included unaffected, adjacent salivary 
gland tissue that was evaluated as an internal control. 
Analysis was performed at 20x-600x magnification on an Olympus BX 51 light 
microscope (Olympus Corporation, Center Valley, PA) by one board-certified oral and 
maxillofacial pathologist and one oral and maxillofacial pathology resident. 
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Results 
IE1-72 Antibody 
 The hCMV-infected cells of the positive control were characterized by a dark brown 
nuclear signal and faint brown, granular cytoplasmic staining (Figure 4c). No staining was 
identified within the negative controls or the sMEC tumor samples (0/23) (Figures 4 and 5, left 
column). 
pp65 Antibody 
 The positive control showed patchy cytoplasmic staining of scant cells. Although the 
same positive control tissue block was used for both antibodies, the proportion of cells staining 
with the pp65 cells was decreased compared to those staining for the IE1-72 antibody (Figure 4, 
a-d). The negative control salivary gland tissue also showed staining, particularly of the normal 
native myoepithelial cell population (Figure 4, f and h). The tumor tissue showed patchy staining 
across all subtypes of neoplastic cells (Figure 5 right column). In the tumors with an internal 
control, the unaffected salivary gland tissue showed equivalent staining to that of the tumor 
tissue (14/23) (Figure 5d). In several specimens, stromal inflammatory cells stained particularly 
intensely (Figure 5h). Without appropriate controls and apparent cross-reactivity, the results of 
this stain were inconclusive.
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Figure 4: IHC controls, IE1-72 and pp65 antibodies. 
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Figure 5: IHC, sMEC reactivity with IE1-72 and pp65 antibodies. 
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Discussion 
 Immunohistochemistry (IHC) is a helpful diagnostic aid to traditional hematoxylin and 
eosin (H&E) pathology. This method allows a suspecting pathologist to test cellular expression 
of specific antigens through the binding of a known antibody coupled with a detection method.7 
While these adjunctive procedures are invaluable and revolutionary to the field of pathology, 
pitfalls confound a correct interpretation or diagnosis. These include biomarkers and/or 
antibodies lacking in specificity or sensitivity, improper tissue fixation or storage, laboratory 
techniques, and errors in interpretation.7 
Some of these errors may explain the failure of our study to reproduce the findings of 
hCMV in sMEC. Melnick et al identified positive staining for hCMV protein IE1-72 in 38/39 of 
tumors studied, while none of our sMEC specimens (0/23) showed positivity using the same 
clone and manufacturer of that antibody.6 IE1-72 is a viral protein that is synthesized in the 
cytoplasm and then localizes to the nucleus in the early stages of infection.8 While some 
reactivity may be seen in the cytoplasm, nuclear staining is expected for positive interpretation 
per the manufacturer. When evaluating the figures of Melnick et al, cytoplasmic staining is 
observed but only 1 of 3 images shows evidence of nuclear staining.6 Our contrasting outcomes 
may be due to differences in interpretation. 
Another cause for discrepancy may involve the laboratory techniques utilized. While the 
underlying chemistry was similar, our study used an automated system and Melnick et al 
performed manual IHC.6 The reproducibility of IHC can be increased with automated systems 
since many steps of the process are operator-dependent and are subject to human error.7, 9 This 
may have led to an increase in the background of their samples being interpreted as positive 
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signal. The differing reagents between the two studies may also be contributory to opposing 
results.6 
In our study, the antibody to hCMV protein pp65 showed unspecific binding, possibly 
due to the polyclonal nature of the antibody cross-reacting with epitopes of the native tissue. This 
manifested in a positive signal in the myoepithelial cells of the negative control as well as 
stromal inflammatory cells and adjacent, unaffected glandular tissue in the tumor specimens. We 
suspect our results were due to error in choosing a sensitive and specific antibody. This antibody 
differed from the one used by Melnick et al due to discontinued production by their manufacturer 
(NCL-CMVpp65 clones 2 and 6 Lecia, Microsystems, Newcastle, UK). While our results were 
inconclusive, another group published negative findings after evaluating four sMEC cases using 
the same Lecia antibody and clones.10 
Immunohistochemistry is accepted as the gold standard for identification of hCMV-
infected tissue, but alternative methods can be used to validate results. Studies have found 
polymerase chain reaction (PCR) techniques to be sensitive and specific for identifying hCMV in 
FFPE tissue.11 Another study of three sMEC cases failed to demonstrate PCR products of major 
immediate early genes of hCMV.12 Larger, more robust studies using PCR, antibodies to 
alternative targets, and/or in-situ hybridization techniques may be indicated to further elucidate 
the role of hCMV in sMEC. 
Conclusions 
 Evidence of hCMV proteins in sMEC was not identified in our specimen samples by 
immunohistochemical techniques, thus viral protein expression could not be used as a prognostic 
factor for these malignancies. 
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